Join
Live feed
·
INSIDERFilingvia Quantisnow
Nurix Therapeutics Inc. logo

Chief Financial Officer Van Houte Hans sold $70,243 worth of shares (6,198 units at $11.33), decreasing direct ownership by 16% to 33,724 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NRIX· Nurix Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRIX (Nurix Therapeutics Inc.) and more on Quantisnow.